Companies / Prime Medicine, Inc.
Prime Medicine, Inc.
Nasdaq: PRMECIK 1894562CAMBRIDGE, MA
Financials · FY2025
Ownership
181.4M shares outstanding · as of Jul 31, 2026
Ownership
| 10%+ / strategic | 3.31% | 5,995,183 |
| Institutions | 52.95% | 96,045,358 |
| Public float | 43.74% | 79,336,315 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 5
View all →| Insider | % of shares | Shares |
|---|---|---|
Alenson CarmanFormerSee Remarks | — | — |
Foster-Cheek Kaye IDirector | — | — |
Lee Ann L.Chief Technical Officer | — | — |
Nelsen RobertDirector · 10% owner | — | — |
Reine AllanCEOChief Executive Officer · Director | — | — |
Institutional holders 189
View all →| Holder | Value | % of shares |
|---|---|---|
| $61.12M | 9.13% | |
| $35.43M | 5.29% | |
| $27.96M | 4.18% | |
| $22.44M | 3.57% | |
| $18.63M | 2.96% | |
| $14.35M | 2.27% | |
| $11.26M | 1.79% | |
| $11.20M | 1.79% | |
| $10.99M | 1.75% | |
| $10.42M | 1.66% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Foster-Cheek Kaye I Director | Grant | Stock Option (right to buy) | — | +75K | 75,000 0.04% of shares | low |
| Jun 5, 2026 | Nelsen Robert Director | Grant | Stock Option (right to buy) | — | +75K | 75,000 0.04% of shares | low |
| Feb 23, 2026 | Lee Ann L. Executive | Grant | Stock Option (right to buy) | — | +375K | 375,000 0.21% of shares | low |
| Feb 26, 2026 | Reine Allan CEO | Grant | Stock Option (right to buy) | — | +1.3M | 1,300,000 0.72% of shares | low |
| Feb 23, 2026 | Alenson Carman Executive | Grant | Stock Option (right to buy) | — | +140K | 140,000 0.08% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| PRME | Common Stock | 74168J101 |